PAHC - Company ID 0001069899
PHIBRO ANIMAL HEALTH CORP trades as PAHC and has a market capitalization of $2.16 B, making it the #2066 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.30B, up 27.4% from the prior year and net income of $48.26M. This page tracks PHIBRO ANIMAL HEALTH CORP through 733 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-06-10
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years PHIBRO ANIMAL HEALTH CORP's revenue grew from $751.53M to $1.30B, a compound annual growth rate of 6.2%. Net profit margin compressed from 11.0% to 3.7% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13D/A | - | 2026-05-22 |
| Insider trade | 4 | 2026-05-07 |
| Major company event | 8-K | 2026-05-06 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-05 |
| SCHEDULE 13G | - | 2026-04-30 |
| Insider trade | 4 | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities Health Care Conference.
Net sales of $383.5 million, an increase of $35.7 million, or 10%
Net sales of $373.9 million, an increase of $64.6 million, or 21%
The largest companies sharing PHIBRO ANIMAL HEALTH CORP's SEC industry classification (pharmaceutical preparations).
PHIBRO ANIMAL HEALTH CORP (PAHC) has a market capitalization of $2.16 B as of 2026-06-10, ranking #2066 among US-listed companies.
PHIBRO ANIMAL HEALTH CORP reported revenue of $1.30B for fiscal year 2025, an increase of 27.4% year over year.
Yes. PHIBRO ANIMAL HEALTH CORP reported net income of $48.26M in its latest fiscal year.